MedTrace Logo

Euclid Phoenix Lens Design Trial

NCT06389916 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-29

No results posted yet for this study

Summary

The "first fit" success rate of the current Euclid orthokeratology "MAX" lens design will be compared to that of the new Euclid orthokeratology MAX "Phoenix" lens design in 30 children.

Conditions

  • Myopia
  • Cornea

Interventions

DEVICE

Euclid orthokeratology MAX (current design)

The current lens design

DEVICE

Euclid orthokeratology MAX Phoenix (new design)

The new lens design

Sponsors & Collaborators

  • Euclid Systems Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-04-30
Completion
2024-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06389916 on ClinicalTrials.gov